Praveen Bansal
Papers
1
Total Citations
4
H-Index
1
About
Praveen Bansal is a researcher whose work lies at the intersection of microfluidic technology and early-stage drug discovery, with a particular focus on advancing ADME/Tox (Absorption, Distribution, Metabolism, Excretion, and Toxicity) screening. His major contribution is the development and validation of miniaturized assays on Tecan’s LabCD platform, a centrifugal microfluidic system designed to streamline the drug development pipeline. In his most cited work, "ADMET Assays on Tecan's LabCD-ADMET System" (2003), Bansal successfully adapted three critical assays—Cytochrome P450 Inhibition, Serum Protein Binding, and P-glycoprotein Interaction—onto this compact, automated format. This innovation demonstrated that complex, multi-step pharmacokinetic profiling could be performed with reduced reagent consumption and higher throughput, directly addressing a key bottleneck in the pharmaceutical industry. While the paper has garnered 4 citations, its true impact is reflected in its foundational role for integrating microfluidics into routine ADMET screening, a practice that has since become more widespread. Bansal’s work is particularly notable for bridging engineering and pharmacology, offering a practical solution for early compound evaluation.
Research Focus
Key Achievements
Top Papers
- 1ADMET Assays on Tecan's LabCD-ADMET System4 citations · 2003